Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era - 05/11/20
Abstract |
It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increased sympathetic outflow, cardiac arrhythmias, ischemia, heart failure, and thromboembolic complications that portend poor outcomes related to COVID-19.
We summarize recent information for hospitalists and internists on the front line of this pandemic regarding its cardiovascular impacts and management and the need for cardiovascular consultation.
Le texte complet de cet article est disponible en PDF.Keywords : Cardiovascular consult, Cardiovascular disease, COVID-19, Multidisciplinary care, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Plan
Funding: None. |
|
Conflicts of Interest: Authors do not have conflicts or funding specific to this manuscript. |
|
Authorship: All authors had access to the data and a role in writing this manuscript. |
Vol 133 - N° 11
P. 1254-1261 - novembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.